Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.
Hugo M AartsNicole D van HemertTimion A MeijsAstrid C van NieuwkerkJurriën M Ten BergJoanna J WykrzykowskaNiels van RoyenCarl E SchotborghPim A L ToninoAlexander IJsselmuidenTessel N VossenbergGert K van HouwelingenTon SlagboomMichiel VoskuilRonak DelewiPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2023)
This systematic review and meta-analysis showed no significant differences in clinical outcomes between patients with concomitant significant CAD who were treated with TAVI with and without preceding PCI at both short- and long-term follow-up. However, there was a higher risk of major bleeding at 30 days in patients undergoing TAVI with preceding PCI. In the context of serious risk of bias in the included studies, results of randomised controlled trials are warranted.
Keyphrases
- transcatheter aortic valve implantation
- percutaneous coronary intervention
- patients undergoing
- coronary artery disease
- aortic stenosis
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- aortic valve
- acute myocardial infarction
- antiplatelet therapy
- aortic valve replacement
- acute coronary syndrome
- coronary artery bypass grafting
- atrial fibrillation
- transcatheter aortic valve replacement
- coronary artery bypass
- left ventricular
- case control